SCHEMBL30778184

SCHEMBL30778184

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.60
▸ GLP1R P43220 11/20 0.58
▸ SCTR P47872 1/20 0.58
▸ CRHR1 P34998 1/20 0.58
▸ CRHR2 Q13324 1/20 0.58
▸ GCGR P47871 1/20 0.54
▸ PTH1R Q03431 1/20 0.54
▸ CCKBR P32239 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29880436 1.00 CALCR (0.60) CALCRGLP1RSCTRCRHR1CRHR2
SCHEMBL29726691 1.00 CALCR (0.60) CALCRGLP1RSCTRCRHR1CRHR2
SCHEMBL29994110 0.98 CALCR (0.58) CALCRGLP1RSCTRCRHR1CRHR2
SCHEMBL31265506 0.97 CALCR (0.60) CALCRGLP1RSCTRCRHR1CRHR2
SCHEMBL29378700 0.94 CALCR (0.54) CALCRGLP1RSCTRCRHR1CRHR2
SCHEMBL29394888 0.94 GLP1R (0.58) CALCRGLP1RSCTRGCGR
SCHEMBL31139948 0.93 GLP1R (0.66) GLP1RSCTRGCGRCCKBR
SCHEMBL31139979 0.92 GLP1R (0.66) GLP1RSCTRGCGR
SCHEMBL30207768 0.92 GLP1R (0.56) CALCRGLP1RSCTRGCGR
SCHEMBL29913342 0.92 GLP1R (0.56) CALCRGLP1RSCTRGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250108118-A1 CHOLIX-DERIVED CARRIERS FOR ORAL DELIVERY OF HETEROLOGOUS PAYLOAD THORNHILL THERAPEUTICS INC (US) 2025-04-03 — — US disclosed
US-20240009316-A1 CHOLIX-DERIVED CARRIERS FOR ORAL DELIVERY OF HETEROLOGOUS PAYLOAD THORNHILL THERAPEUTICS, INC. 2024-01-11 — — US disclosed
Send feedback